NEW YORK (GenomeWeb News) — IBM is donating one of its Blue Gene supercomputers to the Rensselaer Polytechnic Institute, which will use it for biological simulations and computational research, Rensselaer said today.
 
Rensselaer, based in Troy, NY, said the $2.2-million Blue Gene, which IBM awarded under its Shared University Research program, will allow researchers to gain supercomputing experience while it supports projects for developing biological simulation technologies.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.

Aug
27
Sponsored by
Qiagen

This webinar offers a look at how an advanced genetics laboratory implemented and validated a commercial bioinformatics system to help scale its operations.

Oct
02
Sponsored by
Roche

In the last few years several molecular testing methodologies — such as immunohistochemistry, PCR, and sequencing — have been approved by the US Food and Drug Administration to aid in the management of patients with lung cancer.